Association of serum sialic acid and MMP-9 with lipids and inflammatory markers

European Journal of Clinical Investigation

Volumn 30, Issue 2, 2000, Pages 99-104

  Kalela, A ^c   Ponnio M ^a   Koivu, T A ^c   Hoyhtya M ^b   Huhtala, H ^d   Sillanaukee, Pekka ^c,e   Nikkari, S T ^c,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Diabor Oy   (Finland)

^c UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cholesterol; Leukocytes; MMP 9; Sialic acid

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SIALIC ACID;

ADULT; ARTERITIS; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; ARTERIOSCLEROSIS; ARTERITIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; HUMANS; LEUKOCYTE COUNT; LIPIDS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; N-ACETYLNEURAMINIC ACID; RISK FACTORS;

EID: 0033967250     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00607.x     Document Type: Article

References (33)

1. 1 Lindberg G, Råstam L, Lundblad A, Sorlie PD, Folsom AR. The association between serum sialic acid and asymptomatic carotid atherosclerosis is not related to antibodies to herpes type viruses or Chlamydia pneumoniae. The atherosclerosis risk in communities (ARIC) study investigators. Int J Epidemiol 1997;26:1386-91.
2. 2 Lindberg G, Iso H, Råstam L, Lundblad A, Folsom AR. Serum sialic acid and its correlates in community samples from Akita, Japan and Minneapolis, USA. Int J Epidemiol 1997;26:58-63.
3. 3 Crook M, Lumb P, Andrews V, Swaminathan R. Serum total sialic acid, a reputed cardiovascular risk factor, and its relationship to lipids, plasma fasting insulin, blood pressure and body mass index in normal individuals. Clin Sci 1998;95:53-7.
4. 4 Råstam L, Lindberg G, Folsom AR, Burke GL, Nilsson-Ehle P, Lundblad A. Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound. The ARIC investigators. Atherosclerosis risk in communities study. Int J Epidemiol 1996;25:953-8.
5. 5 Sillanaukee P, Pönniö M, Jääskeläinen IP. Occurrence of sialic acids in healthy humans and different disorders. Eur J Clin Invest 1999;29:413-25.
6. 6 Orekhov AN, Tertov VV, Sobenin IA, Smirnov VN, Via DP et al. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J Lipid Res 1992;33:805-17.
7. 7 Melajärvi N, Gylling H, Miettinen TA. Sialic acids and the metabolism of low density lipoprotein. J Lipid Res 1996;37:1625-31.
8. 8 Myara I, Haberland ME, Demuth K, Chappey B, Moatti N. Susceptibility to copper oxidation of neuraminidase-treated LDL. Clin Chim Acta 1995;240:221-3.
9. 9 Orekhov AN, Tertov VV, Mukhin DN. Desialylated low density lipoprotein: naturally occuring modified lipoprotein with atherogenic potency. Atherosclerosis 1991;86:153-61.
10. 10 Ruelland A, Gallou G, Legras B, Paillard F, Cloarec L. LDL sialic acid content in patients with coronary artery disease. Clin Chim Acta 1993;221:127-33.
11. 11 Chappey B, Beyssen B, Foos E, Ledru F, Guermonprez JL et al. Sialic acid content of DDL in coronary artery disease: no evidence of desialylation in subjects with coronary stenosis and increased levels in subjects with extensive atherosclerosis and acute myocardial infarction: relation between desialylation and in vitro peroxidation. Arterioscler Thromb Vase Biol 1998;18:876-83.
12. 12 Chappey B, Myara I, Giral P, Kerharo G, Plainfosse MC et al. Evaluation of the sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects. PCVMETRA Group Arterioscler Thromb Vase Biol 1995;15:334-9.
13. 13 Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995;77:863-8.
14. 14 Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-503.
15. 15 Sorbi D, French DL, Nuovo GJ, Kew RR, Arbeit LA, Gruber BL. Elevated levels of 92-kd type IV collagenase (Matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 1996;39:1747-53.
16. 16 Nikkari ST, Höyhtyä M, Isola J, Nikkari T. Macrophages contain 92-kD gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996;149:1427-33.
17. 17 Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation 1995;91:2125-31.
18. 18 Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ. Expression of matrix metalloproteinase 9 (96-kD gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 1996;39:1576-87.
19. 19 Kolkhorst V, Sturzebecher J, Wiederanders B. Inhibition of tumour cell invasion by protease inhibitors: correlation with the protease profile. J Cancer Res Clin Oncol 1998;124:598-606.
20. 20 Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959;34:1971-5.
21. 21 Crook M, Haq M, Tutt P. Evaluation of three assays for the determination of serum total sialic acid. Clin Biochem 1993;26:449-54.
22. 22 Soini Y, Hurskainen T, Höyhtyä M, Oikarinen A, Autio-Harmainen H. 72 kD and 92 kD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J Histochem Cytochem 1994;42:945-51.
23. 23 Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996;312:1061-5.
24. 24 Wakabayashi I, Sakamoto K, Yoshimoto S, Kakishita E. Serum sialic acid concentration and atherosclerotic risk factors. J Atheroscler Thromb 1994;1:113-7.
25. 25 Crook M, Haq M, Haq S, Tutt P. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction. Angiology 1994;45:709-15.
26. 26 Pickup JC, Mattock MB, Crook MA, Gary DC, Burt D, Fitzgerald AP. Serum sialic acid concentration and coronary heart disease in NIDDM. Diabetes Care 1995;18:1100-3.
27. 27 Salomone OA, Crook JR, Hossein-Nia M, Holt D, Kaski JC. Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris. Am Heart J 1998;136:620-3.
28. 28 Demuth K, Myara I, Chappey B, Vedie B, Pech-Amsellem MA et al. A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler Thromb Vasc Biol 1996;16:773-83.
29. 29 Tertov VV, Kaplun VV, Sobenin IA, Orekhov AN. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Atherosclerosis 1998;138:183-95.
30. 30 Celentano DC, Frishman MD. Matrix metalloproteinases and coronary artery disease: a novel therapeutic target. J Clin Pharmacol 1997;37:991-1000.
31. 31 Nikkari ST, Geary RL, Hatsukami T, Ferguson M, Forough R et al. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy. Am J Pathol 1996;148:777-83.
32. 32 Di Girolamo N, Tedla N, Lloyd A, Wakefield D. Expression of matrix metalloproteinases by human plasma cells and B lymphocytes. Eur J Immunol 1998;28:1773-84.
33. 33 Ohno I, Ohtani H, Nitta Y, Suzuki J, Hoshi H et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 1997;16:212-9.